Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: Evidence from epidemiologic studies and clinical trials

Seminars in Reproductive Medicine

Volumn 27, Issue 3, 2009, Pages 275-282

  Barrett Connor, Elizabeth ^a,b   Laughlin, Gail A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive function; Dementia; Estrogen

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ALLELE; ALZHEIMER DISEASE; BONE DENSITY; BRAIN TISSUE; CELL FUNCTION; CLINICAL TRIAL; COGNITION; DEMENTIA; DIAGNOSTIC TEST; DRUG BIOAVAILABILITY; DRUG EFFECT; ESTROGEN THERAPY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; MENOPAUSE; NEUROPROTECTION; OBSERVATIONAL STUDY; POSTMENOPAUSE; RATING SCALE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; VERBAL MEMORY;

BRAIN; COGNITION; DEMENTIA; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; POSTMENOPAUSE; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649653772     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0029-1216280     Document Type: Review

References (50)

1. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307
2. Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates. Neuroscience 2006;138: 859-867 (Pubitemid 43306826)
3. Barrett-Connor E, Kritz-Silverstein D. Gender differences in cognitive function with age: the Rancho Bernardo study. J Am Geriatr Soc 1999;47:159-164 (Pubitemid 29082715)
4. de Frias CM, Nilsson LG, Herlitz A. Sex differences in cognition are stable over a 10-year period in adulthood and old age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2006;13:574-587 (Pubitemid 44196016)
5. Aartsen MJ, Martin M, Zimprich D. Gender differences in level and change in cognitive functioning. Results from the Longitudinal Aging Study Amsterdam. Gerontology 2004;50: 35-38
6. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001;153:132-136
7. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-1997
8. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-654
9. Pardridge WM, Mietus LJ. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albuminbound hormone. J Clin Invest 1979;64:145-154 (Pubitemid 9216529)
10. Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 1998; 46:816-821 (Pubitemid 28328494)
11. Yaffe K, Lui LY, Grady D, Cauley J, Kramer J, Cummings SR. Cognitive decline in women in relation to non-proteinbound oestradiol concentrations. Lancet 2000;356:708-712 (Pubitemid 30663239)
12. Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 1999;47:1289-1293 (Pubitemid 29523197)
13. den Heijer T, Geerlings MI, Hofman A, et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol 2003;60: 213-220 (Pubitemid 36193965)
14. Lebrun CE, van der Schouw YT, de Jong FH, Pols HA, Grobbee DE, Lamberts SW. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) 2005;63:50-55 (Pubitemid 40966402)
15. Hogervorst E, Williams J, Combrinck M, David Smith A. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol 2003;148:67-72 (Pubitemid 36176006)
16. Geerlings MI, Launer LJ, de Jong FH, et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 2003;53:607-615 (Pubitemid 36529434)
17. Low LF, Anstey KJ, Jorm AF, Rodgers B, Christensen H. Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60- 64 years. Climacteric 2005;8:380-389 (Pubitemid 41617487)
18. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 2003;60:1369-1371 (Pubitemid 36461000)
19. Geerlings MI, Ruitenberg A, Witteman JC, et al. Reproductive period and risk of dementia in postmenopausal women. JAMA 2001;285:1475-1481 (Pubitemid 32221896)
20. Yaffe K, Browner W, Cauley J, Launer L, Harris T. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 1999;47:1176-1182 (Pubitemid 29473288)
21. Lui LY, Stone K, Cauley JA, Hillier T, Yaffe K. Bone loss predicts subsequent cognitive decline in older women: the Study of Osteoporotic Fractures. J Am Geriatr Soc 2003;51: 38-43 (Pubitemid 36119932)
22. Sullivan Mitchell E, Fugate Woods N. Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study. J Womens Health Gend Based Med 2001;10:351-362 (Pubitemid 32976194)
23. Luetters C, Huang MH, Seeman T, et al. Menopause transition stage and endogenous estradiol and folliclestimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN). J Womens Health (Larchmt) 2007;16:331-344 (Pubitemid 46668914)
24. Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 2007;14:425-431
25. Kok HS, Kuh D, Cooper R, et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 2006;13:19-27 (Pubitemid 43755893)
26. Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006;53:447-453
27. Elsabagh S, Hartley DE, File SE. Cognitive function in late versus early postmenopausal stage. Maturitas 2007;56:84-93
28. Matthews KA, Kuller LH, Wing RR,Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-978
29. Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the lieterature. J Clin Epidimiol 1997;50: 1249-1264
30. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101:485-512 (Pubitemid 30953107)
31. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-1499 (Pubitemid 32221898)
32. Kang JH, Weuve J, Grodstein F. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 2004;63:101-107 (Pubitemid 38943786)
33. Matthews K, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999;47:518-523 (Pubitemid 29215577)
34. Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. Arch Intern Med 2000;160: 1641-1649 (Pubitemid 30367903)
35. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641 (Pubitemid 23147699)
36. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156:2213-2217 (Pubitemid 26361914)
37. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288: 2123-2129 (Pubitemid 35265379)
38. Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 2001;58: 435-440 (Pubitemid 32217460)
39. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 2008;29: 88-113
40. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998;91: 459-466 (Pubitemid 28119853)
41. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281: 1197-1202 (Pubitemid 29163128)
42. Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) 2000;149:129-139 (Pubitemid 30238950)
43. Yaffe K, Vittinghoff E, Ensrud KE, et al. Effects of ultralow- dose transdermal estradiol on cognition and healthrelated quality of life. Arch Neurol 2006;63:945-950 (Pubitemid 44036294)
44. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett- Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med 2002;113:543-548 (Pubitemid 35379908)
45. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968 (Pubitemid 38802685)
46. Resnick SM, MakiPM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-1810
47. Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2008; (1):CD003122 (Pubitemid 351807570)
48. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005;12:12-17 (Pubitemid 40204888)
49. Petitti DB, Crooks VC, Chiu V, Buckwalter JG, Chui HC. Incidence of dementia in long-term hormone users. Am J Epidemiol 2008;167:692-700
50. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432 (Pubitemid 26267873)